Completed PHASE1 INTERVENTIONAL 1-arm NCT00641615

Peptide Vaccine and S-1/CPT-11 Therapy for Patients With Unresectable Advanced Colorectal Cancer

Phase I Study of Peptide Vaccine and S-1 Plus CPT-11 Chemotherapy in Patients With Unresectable Recurrent or Metastatic Colorectal Cancer

Sponsor: Human Genome Center, Institute of Medical Science, University of Tokyo

Conditions Colorectal Cancer

Interventions RNF43-721

Updated 5 times since 2017 Last updated: May 11, 2015 Started: May 31, 2007 Primary completion: Jul 31, 2011 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00641615, this PHASE1 trial focuses on Colorectal Cancer and remains completed. Sponsored by Human Genome Center, Institute of Medical Science, University of Tokyo, it has been updated 5 times since 2007, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

May 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Human Genome Center, Institute of Medical Science, University of Tokyo
Kazuhiko Yoshimatsu

Data source: Tokyo Women's Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tokyo, Japan